Aehr Test Systems (US.AEHR)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.AEHR · YoY: 2026 ANNUAL vs 2025 ANNUAL
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 162.4% | → |
| ROE | -3.2% | → |
| Cash Conversion | - | → |
| D/E Ratio | 0.05 | ↑ |
| Gross Margin | 35.3% | ↓ |
US.AEHR (Aehr Test Systems) | YoY: 2026 ANNUAL vs 2025 ANNUAL Metric Value YoY ---------------------------- FCF Conversion 162.4% → ROE -3.2% → Cash Conversion - → D/E Ratio 0.05 ↑ Gross Margin 35.3% ↓
Key Metrics
US.AEHR (Aehr Test Systems) | YoY: 2026 ANNUAL vs 2025 ANNUAL
Metric Value YoY----------------------------FCF Conversion 162.4% →ROE -3.2% →Cash Conversion - →D/E Ratio 0.05 ↑Gross Margin 35.3% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies